Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 24.62 Delayed Data As of 3:59pm ET |  +0.55 / +2.29%Today’s Change | 17.92 Today|||52-Week Range 44.48 | -18.45% Year-to-Date |
| Previous close | 24.07 |
| Today’s open | 24.15 |
| Day’s range | 23.98 - 24.66 |
| Volume | 334,534 |
| Average volume (3 months) | 850,590 |
| Market cap | $822.1M |
| Dividend yield | -- |
| Earnings growth (last year) | -82.73% |
| Earnings growth (this year) | +477.30% |
| Earnings growth (next 5 years) | -0.61% |
| Revenue growth (last year) | +236.28% |
| P/E ratio | NM |
| Price/Sales | 2.55 |
| Price/Book | 0.90 |
| Today’s change | Today’s % change | |
|---|---|---|
| RTRXRetrophin Inc | -0.12 | -0.54% |
| MNTAMomenta Pharmaceutic... | +0.22 | +1.89% |
| ANIPANI Pharmaceuticals ... | +2.90 | +4.44% |
| BPMCBlueprint Medicines ... | +0.35 | +1.28% |
| Next reporting date | October 27, 2016 |
| EPS forecast (this quarter) | $1.44 |
| Annual revenue (last year) | $418.3M |
| Annual profit (last year) | $32.8M |
| Net profit margin | 7.84% |
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Executive Director William K. Heiden |
President & Chief Operating Officer Frank E. Thomas |
Corporate headquarters Waltham, Massachusetts |
